Remove 2023 Remove Clinic Remove Complication Remove Electronics
article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

Yes, one year after stopping the medication, patients regain ½ – ⅔ of their previous weight loss: What are other clinical benefits? The study was terminated early because benefits were already significantly visible by October 2023. Tirzepatide (15 mg) showed slightly more noticeable effects than Semaglutide (2.4 semaglutide 2.4

Diabetes 130
article thumbnail

Transition Plans for Covid-19 Products are Amongst CDRH FY2023 Priorities

FDA Law

On October 17, 2022, FDA published the list of CDRH proposed guidances for FY 2023 (see here ). electronic thermometers, single lumen needles, piston syringes). The 2013 guidance documents include, but are not limited to, in vitro diagnostic and clinical trial considerations.

Medical 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Good, Bad, and Ugly side of 510(k)s—HP&M’s Early Experience with the eSTAR Template for 510(k)s

FDA Law

FDA announced on October 3, 2022 that the voluntary electronic Submission Template And Resource (eSTAR) templates would be required beginning October 1, 2023, as we blogged about here. As anyone who has ever worked on a lengthy and/or complicated AI response knows, these responses do not always fit neatly in a text box.

article thumbnail

Future Directions in Opioid Prescribing Patterns for Patients with Chronic Pain [Prescribing and pharmacotherapeutics]

Annals of Family Medicine

Objective: 1) Demonstrate the feasibility of collecting data from prescription drug monitoring programs (PDMPs) for population health reporting, 2) analyze trends in PDMP and electronic health record patient data relative to CDC guidelines and 3) identify use of patient-centered measures for pain management in primary care.

Patients 130
article thumbnail

Texas invests $50M in psychedelic drug research to treat addiction

Medical Xpress

The goal is to support clinical trials and bring in another $50 million in private investment to help ibogaine win approval from the U.S. Other states like Oregon and Colorado have already launched legal clinics using psilocybin, the compound found in mushrooms, The Times reported. Food and Drug Administration (FDA).

article thumbnail

Rewiring the body clock: Deep brain imaging reveals unexpected complexity in jet lag adjustment

Medical Xpress

But what we observed was much more complicated." The traditional model is simple: SCN neurons were believed to act like runners in a relay race, passing the light signal along in a linear chain. Some SCN neurons were activated by light, while others were inhibited. Consider supporting Science Xs mission by getting a premium account.

Provider 109
article thumbnail

Buckle Up: DOJ Initiates Rulemaking to Reschedule Marijuana

FDA Law

Public comments must be submitted electronically or postmarked on or before July 22, 2024, 60 days after publication in the Federal Register. 29, 2023) (“Basis”); NPRM at 44,603. In 2023, HHS conducted a different approach, a two-part test, to determine whether marijuana has a CAMU. 21 U.S.C. § NPRM at 44,607. NPRM at 44,617.